Champions Oncology
CSBR
About: Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Employees: 306
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
0% more funds holding in top 10
Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]
1.04% less ownership
Funds ownership: 42.79% [Q1] → 41.75% (-1.04%) [Q2]
9% less funds holding
Funds holding: 34 [Q1] → 31 (-3) [Q2]
17% less capital invested
Capital invested by funds: $51.4M [Q1] → $42.5M (-$8.82M) [Q2]
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Financial journalist opinion
Based on 4 articles about CSBR published over the past 30 days
